Tweet
Italy - Influenza A/H1N1 - Situation Update - week 52 (21-27 December) (Min Health, edited) - CASES: ILI (Cum.) 3,967,000, Hospitalized 923, in ICU 446, Deaths (Cum.) 193
Influenza A/H1N1 - Situation Update - week 52 (21-27 December) (Min Health, edited)
[Source RTF Document (in Italian): LINK. Edited. Warning: Google Machine Translation.]
Press Release No 618 - 31 December 2009 - Ministry of Health - PRESS OFFICE
Updates
- The estimated new cases of the flu syndrome in the 52nd week (December 21 to 27) are 73,000, for a total of 3,950,000 cases from 19 October when it began monitoring Influnet current season.
- Are reducing access to emergency care and slightly increases the number of hospitalizations for acute respiratory syndrome, for all age groups.
- Cases that require respiratory assistance to 30 December: 446
- Percentage of cases that require respiratory assistance in relation to the total of patients: 0.011
- In the 52nd week (December 21 to 27) were first administered 6206 doses 2802 and second doses. Start of the vaccination campaign, a total of 812,559 first doses were administered, and 26,418 second doses. Data on the number of vaccine doses administered during 52 weeks (21-27 December 2009) were reported from 10 regions and autonomous provinces
- A total of 10,047,421 doses of vaccine distributed
- Total estimated cases of influenza since the beginning of the pandemic at 27 December: 3,967,000
- Total deaths related to the new influenza A/H1N1 to 27 December: 193
- Percentage of victims in relation to the total of people with new influenza A: 0.0048 percent
Epidemic surveillance
Cases and incidence
The estimated new cases of the flu syndrome in the 52nd week are 73,000, for a total of 3,950,000 cases from the beginning of the surveillance Influnet (43 weeks: 19-25 October). For a total count since last May, these should be added about 17,000 cases reported previously by other surveillance systems for a total of 3,967,000 cases.
The total value of the impact of the flu syndrome in week 52 is equal to 1.22 cases per thousand assisted, down to the value observed in the previous week (1.78 cases per thousand power). The regions where in week 52 has the highest number of cases in the population under observation are Sardinia with an incidence of 1 per cent, Molise (0.3%), Marche (0.2%).
The age group most affected is always the pediatric (0-14 years), with an incidence equal to 2.63 cases per thousand assisted (3.61 per thousand in the range of younger children of 0-4 years and 2 14 per thousand in the range 5-14 years).
There is a decline in the incidence in all age groups although more accentuated in pediatric fields.
Cases that require respiratory assistance
The regions have reported so far at the Ministry of 923 hospital admissions for severe cases of influenza, of which 446 have required ventilatory support: a fee equal to 0.011 percent of the estimated total of people who contract the new flu A.
The data may suffer from continuous updates depending on the availability of laboratory confirmation of severe cases reported, therefore are subject to change from week to week.
Victims related to influenza A
The percentage of victims related to influenza A has been updated compared to the total number of cases estimated by Influnet and is equal to 0.0048 percent of patients, compared with 0.2 percent of the victims related to the normal flu. Must be considered that the percentage of victims being calculated considering the clinical cases reported to the surveillance system, because these are most likely underestimated, the value might be even lower than the estimate above.
At week 52, the overall figure of deaths is 193. This number includes cases for which the regional health authorities have confirmed the finding of infection by the new A/H1N1.
Situation in Italy
Total casualties 193
- Region
- Abruzzi 3
- Basilicata 1
- Calabria 14
- Campania 48
- Emilia Romagna 12
- Friuli Venezia Giulia 3
- Lazio 14
- Liguria 3
- Lombardy 13
- Marches 3
- Molise 4
- Piedmont 12
- Puglia 29
- Sicily 14
- Tuscany 5
- Umbria 3
- Veneto 10
- P.a. Bolzano 1
- P.a. Trento 1
Situation in Europe (source ECDC)
Total casualties in 1869
in
- Great Britain 303
- Spain 256
- France 191
World situation (source ECDC)
Total victims 12866
of which:
- United States of America 2160
- Brazil 1632
- Mexico 823
- Argentina 617
Access to emergency
The network of sentinel emergency rooms reported that in 52 weeks (December 21 to 27), 6.3% of all persons who have turned to the emergency room was visited by acute respiratory syndrome. Of these, 24.7% were hospitalized
Decreased access to emergency care and slightly increases the number of hospitalizations for acute respiratory syndrome, for all age groups. However, none of the observed values exceed the two thresholds of alert calculated by the model. The analysis of national data is based on information from 53 of the 59 emergency room that joined the surveillance. While reflecting the different modes of access to the emergency room, the system can be readily detected the trend of accesses for respiratory syndrome, an indirect indicator of increased activity of influenza viruses.
Vaccination of the population
Data on the number of vaccine doses administered during the 52 weeks (21-27 December 2009) were reported from 10 regions and autonomous provinces. In the 52 weeks were administered doses of 6206 and 2802 first second doses. Start of the vaccination campaign, a total of 812,559 first doses were administered, and 26,418 second doses.
Health professionals, social and health that have vaccinated 159,093, equal to 15% of the total.
Women in the second and third trimester of pregnancy were administered 22,249 doses (12% of total), people aged between 6 months and 65 years with risk conditions were administered 510,726 doses (12%) while children 1497 born preterm doses (7%).
Some regions have already begun to vaccinate children and young adults between 6 months and 17 years without risk conditions (15,894 doses) and the holders of at least one of the conditions of risk over the age of 65 years (9,225 doses).
Vaccine distribution
Ended December 22 eighth deployment to the Regions and Autonomous Provinces of pandemic vaccines. The doses delivered to the Regions and Autonomous Provinces as of 12 October were 10,047,421.
Government Actions
Background
The World Health Organization on 11 June 2009 has declared a state of pandemic influenza with the transition to the phase of maximum alert.
The infection is caused by a new influenza virus H1N1 that has spread from Mexico in March 2009 from around the world.
The government immediately took all measures to counter the spread of new influenza A and protect the health of citizens.
The Ministry has set April 24 a special Crisis Unit headed by Deputy Ferruccio Fazio. Here are the main actions:
Control and containment stage
In the first phase of the spread of the disease were applied to all measures of infection control and containment measures to limit the spread of the virus. This avoided in our country a first wave of summer 2009 epidemic first hand that occurred in other European countries. Among the preventive measures more effective, please note the early identification of cases in travelers from affected areas, prophylaxis of their close contacts, promotion of hygiene rules and protective equipment such as hand washing.
Vaccination of the population
The Government has set up a vaccination strategy to cope with the new wave of epidemic influenza A (H1N1) in place in the 2009-2010 influenza season and eradicate the epidemic of new virus A (H1N1) in our country. E 'planned vaccination of 40% of the Italian population from the employees of essential services like health care personnel, and groups at risk of complications (children and adults with chronic diseases in the age group 6 months to 64 years, women pregnancy in the second and third quarter). E 'active monitoring of the vaccination campaign.
Stocks of antivirals
The Ministry has forty million doses of antiviral drugs, including three in the form of the active powder which, as they have gradually become encapsulated Military Chemical Pharmaceutical Institute in Florence, are distributed to the regions. The Ministry has also issued specific recommendations for proper use of antivirals.
Management of severe cases
The Ministry has provided a first guide to operators in the management of serious and complicated by new influenza virus A (H1N1) and promoted by the regions and autonomous provinces to identify the centers that make for prospective patients suffering from acute respiratory failure. It also defines the criteria for the management of patients, particularly regarding access to the ICU and the next location within the intensive care centers that make up regional networks.
Epidemic surveillance
Starting from 19 October 2009, the influenza surveillance system is based on Influnet, which collects the cases of the network of sentinel physicians reported among its clients as well as data on viruses circulating the network of accredited laboratories. The ISS also conducts random confirmation of clinical cases of serious and deepening virologic to monitor the possible emergence of resistance to antiviral drugs and record any changes in the pandemic virus.
The Ministry also conducts monitoring of hospitalized cases, of serious and deaths.
Sentinel surveillance of access to Emergency
The Ministry of Higher Health Institute have launched in collaboration with the Regional Monitoring of accesses to a specific emergency room. The data will be transmitted on a weekly basis.
Pharmacovigilance
Part of action coordinated by the crisis, the Italian Drug Agency (AIFA) has prepared a National Plan of Pharmacovigilance for monitoring the safety of pandemic vaccines and antivirals. The system has been running since October.
International Epidemiological updates
The World Health Organization November 20 reported that in Norway there was a mutation of the virus in some samples of the new AH1N1 influenza virus isolated in three patients, of whom two died. The mutation is charged with the hemagglutinin (viral protein surface) of the new influenza virus A/H1N1, and causes the substitution of a single amino acid (a glycine instead of aspartic acid). The same mutation was observed in sporadic cases, since last April, in several countries around the world both in patients with severe pneumonia and patients with benign course of disease. Following these reports, the National Institute of Health has reassessed the sequences of more than 100 strains identified by as many patients diagnosed in recent months in various Italian regions. The mutation has been found so far in only one patient suffering from a severe form of pneumonia resolved following treatment with ECMO performed in intensive care. None of the other patients examined, including those with serious or life-threatening events, showed that mutation. The Italian data confirmed that the mutation in question is not to be currently predominant in cases of serious or deadly new flu in addition, the same mutation has a sporadic and does not seem at this stage in the process of diffusion.
Distribution antivirals
It 'was released on 20 November at the Regions and Autonomous Provinces Ministerial Circular "Distribution antiviral drugs to assist Territorial reaffirming the guidance for the administration of antiviral drugs and methods of distribution on the territory of the competent local companies.
Surveillance of hospitalizations
E 'was issued November 20, 2009 to the Regions and Autonomous Provinces the ministerial circular "Supervision of hospitalizations, the serious and complicated and deaths of New Avian influenza virus A (H1N1) viruses and detection of vaccine coverage for the pandemic vaccine," updating the reporting form and procedures for its transmission.
Read more
All information on government, the questions and answers, rules and documentation for operators on www.ministerosalute.it, games and interactive tests to understand and better combat the virus A/H1N1al site www.fermailvirus . com.
Information also via phone by calling the call center 1500 of the Ministry, available Monday to Friday from 8.00 to 18.00.
--
------
[Source RTF Document (in Italian): LINK. Edited. Warning: Google Machine Translation.]
Press Release No 618 - 31 December 2009 - Ministry of Health - PRESS OFFICE
Updates
- The estimated new cases of the flu syndrome in the 52nd week (December 21 to 27) are 73,000, for a total of 3,950,000 cases from 19 October when it began monitoring Influnet current season.
- Are reducing access to emergency care and slightly increases the number of hospitalizations for acute respiratory syndrome, for all age groups.
- Cases that require respiratory assistance to 30 December: 446
- Percentage of cases that require respiratory assistance in relation to the total of patients: 0.011
- In the 52nd week (December 21 to 27) were first administered 6206 doses 2802 and second doses. Start of the vaccination campaign, a total of 812,559 first doses were administered, and 26,418 second doses. Data on the number of vaccine doses administered during 52 weeks (21-27 December 2009) were reported from 10 regions and autonomous provinces
- A total of 10,047,421 doses of vaccine distributed
- Total estimated cases of influenza since the beginning of the pandemic at 27 December: 3,967,000
- Total deaths related to the new influenza A/H1N1 to 27 December: 193
- Percentage of victims in relation to the total of people with new influenza A: 0.0048 percent
Epidemic surveillance
Cases and incidence
The estimated new cases of the flu syndrome in the 52nd week are 73,000, for a total of 3,950,000 cases from the beginning of the surveillance Influnet (43 weeks: 19-25 October). For a total count since last May, these should be added about 17,000 cases reported previously by other surveillance systems for a total of 3,967,000 cases.
The total value of the impact of the flu syndrome in week 52 is equal to 1.22 cases per thousand assisted, down to the value observed in the previous week (1.78 cases per thousand power). The regions where in week 52 has the highest number of cases in the population under observation are Sardinia with an incidence of 1 per cent, Molise (0.3%), Marche (0.2%).
The age group most affected is always the pediatric (0-14 years), with an incidence equal to 2.63 cases per thousand assisted (3.61 per thousand in the range of younger children of 0-4 years and 2 14 per thousand in the range 5-14 years).
There is a decline in the incidence in all age groups although more accentuated in pediatric fields.
Cases that require respiratory assistance
The regions have reported so far at the Ministry of 923 hospital admissions for severe cases of influenza, of which 446 have required ventilatory support: a fee equal to 0.011 percent of the estimated total of people who contract the new flu A.
The data may suffer from continuous updates depending on the availability of laboratory confirmation of severe cases reported, therefore are subject to change from week to week.
Victims related to influenza A
The percentage of victims related to influenza A has been updated compared to the total number of cases estimated by Influnet and is equal to 0.0048 percent of patients, compared with 0.2 percent of the victims related to the normal flu. Must be considered that the percentage of victims being calculated considering the clinical cases reported to the surveillance system, because these are most likely underestimated, the value might be even lower than the estimate above.
At week 52, the overall figure of deaths is 193. This number includes cases for which the regional health authorities have confirmed the finding of infection by the new A/H1N1.
Situation in Italy
Total casualties 193
- Region
- Abruzzi 3
- Basilicata 1
- Calabria 14
- Campania 48
- Emilia Romagna 12
- Friuli Venezia Giulia 3
- Lazio 14
- Liguria 3
- Lombardy 13
- Marches 3
- Molise 4
- Piedmont 12
- Puglia 29
- Sicily 14
- Tuscany 5
- Umbria 3
- Veneto 10
- P.a. Bolzano 1
- P.a. Trento 1
Situation in Europe (source ECDC)
Total casualties in 1869
in
- Great Britain 303
- Spain 256
- France 191
World situation (source ECDC)
Total victims 12866
of which:
- United States of America 2160
- Brazil 1632
- Mexico 823
- Argentina 617
Access to emergency
The network of sentinel emergency rooms reported that in 52 weeks (December 21 to 27), 6.3% of all persons who have turned to the emergency room was visited by acute respiratory syndrome. Of these, 24.7% were hospitalized
Decreased access to emergency care and slightly increases the number of hospitalizations for acute respiratory syndrome, for all age groups. However, none of the observed values exceed the two thresholds of alert calculated by the model. The analysis of national data is based on information from 53 of the 59 emergency room that joined the surveillance. While reflecting the different modes of access to the emergency room, the system can be readily detected the trend of accesses for respiratory syndrome, an indirect indicator of increased activity of influenza viruses.
Vaccination of the population
Data on the number of vaccine doses administered during the 52 weeks (21-27 December 2009) were reported from 10 regions and autonomous provinces. In the 52 weeks were administered doses of 6206 and 2802 first second doses. Start of the vaccination campaign, a total of 812,559 first doses were administered, and 26,418 second doses.
Health professionals, social and health that have vaccinated 159,093, equal to 15% of the total.
Women in the second and third trimester of pregnancy were administered 22,249 doses (12% of total), people aged between 6 months and 65 years with risk conditions were administered 510,726 doses (12%) while children 1497 born preterm doses (7%).
Some regions have already begun to vaccinate children and young adults between 6 months and 17 years without risk conditions (15,894 doses) and the holders of at least one of the conditions of risk over the age of 65 years (9,225 doses).
Vaccine distribution
Ended December 22 eighth deployment to the Regions and Autonomous Provinces of pandemic vaccines. The doses delivered to the Regions and Autonomous Provinces as of 12 October were 10,047,421.
Government Actions
Background
The World Health Organization on 11 June 2009 has declared a state of pandemic influenza with the transition to the phase of maximum alert.
The infection is caused by a new influenza virus H1N1 that has spread from Mexico in March 2009 from around the world.
The government immediately took all measures to counter the spread of new influenza A and protect the health of citizens.
The Ministry has set April 24 a special Crisis Unit headed by Deputy Ferruccio Fazio. Here are the main actions:
Control and containment stage
In the first phase of the spread of the disease were applied to all measures of infection control and containment measures to limit the spread of the virus. This avoided in our country a first wave of summer 2009 epidemic first hand that occurred in other European countries. Among the preventive measures more effective, please note the early identification of cases in travelers from affected areas, prophylaxis of their close contacts, promotion of hygiene rules and protective equipment such as hand washing.
Vaccination of the population
The Government has set up a vaccination strategy to cope with the new wave of epidemic influenza A (H1N1) in place in the 2009-2010 influenza season and eradicate the epidemic of new virus A (H1N1) in our country. E 'planned vaccination of 40% of the Italian population from the employees of essential services like health care personnel, and groups at risk of complications (children and adults with chronic diseases in the age group 6 months to 64 years, women pregnancy in the second and third quarter). E 'active monitoring of the vaccination campaign.
Stocks of antivirals
The Ministry has forty million doses of antiviral drugs, including three in the form of the active powder which, as they have gradually become encapsulated Military Chemical Pharmaceutical Institute in Florence, are distributed to the regions. The Ministry has also issued specific recommendations for proper use of antivirals.
Management of severe cases
The Ministry has provided a first guide to operators in the management of serious and complicated by new influenza virus A (H1N1) and promoted by the regions and autonomous provinces to identify the centers that make for prospective patients suffering from acute respiratory failure. It also defines the criteria for the management of patients, particularly regarding access to the ICU and the next location within the intensive care centers that make up regional networks.
Epidemic surveillance
Starting from 19 October 2009, the influenza surveillance system is based on Influnet, which collects the cases of the network of sentinel physicians reported among its clients as well as data on viruses circulating the network of accredited laboratories. The ISS also conducts random confirmation of clinical cases of serious and deepening virologic to monitor the possible emergence of resistance to antiviral drugs and record any changes in the pandemic virus.
The Ministry also conducts monitoring of hospitalized cases, of serious and deaths.
Sentinel surveillance of access to Emergency
The Ministry of Higher Health Institute have launched in collaboration with the Regional Monitoring of accesses to a specific emergency room. The data will be transmitted on a weekly basis.
Pharmacovigilance
Part of action coordinated by the crisis, the Italian Drug Agency (AIFA) has prepared a National Plan of Pharmacovigilance for monitoring the safety of pandemic vaccines and antivirals. The system has been running since October.
International Epidemiological updates
The World Health Organization November 20 reported that in Norway there was a mutation of the virus in some samples of the new AH1N1 influenza virus isolated in three patients, of whom two died. The mutation is charged with the hemagglutinin (viral protein surface) of the new influenza virus A/H1N1, and causes the substitution of a single amino acid (a glycine instead of aspartic acid). The same mutation was observed in sporadic cases, since last April, in several countries around the world both in patients with severe pneumonia and patients with benign course of disease. Following these reports, the National Institute of Health has reassessed the sequences of more than 100 strains identified by as many patients diagnosed in recent months in various Italian regions. The mutation has been found so far in only one patient suffering from a severe form of pneumonia resolved following treatment with ECMO performed in intensive care. None of the other patients examined, including those with serious or life-threatening events, showed that mutation. The Italian data confirmed that the mutation in question is not to be currently predominant in cases of serious or deadly new flu in addition, the same mutation has a sporadic and does not seem at this stage in the process of diffusion.
Distribution antivirals
It 'was released on 20 November at the Regions and Autonomous Provinces Ministerial Circular "Distribution antiviral drugs to assist Territorial reaffirming the guidance for the administration of antiviral drugs and methods of distribution on the territory of the competent local companies.
Surveillance of hospitalizations
E 'was issued November 20, 2009 to the Regions and Autonomous Provinces the ministerial circular "Supervision of hospitalizations, the serious and complicated and deaths of New Avian influenza virus A (H1N1) viruses and detection of vaccine coverage for the pandemic vaccine," updating the reporting form and procedures for its transmission.
Read more
All information on government, the questions and answers, rules and documentation for operators on www.ministerosalute.it, games and interactive tests to understand and better combat the virus A/H1N1al site www.fermailvirus . com.
Information also via phone by calling the call center 1500 of the Ministry, available Monday to Friday from 8.00 to 18.00.
--
------